Jeff L. Vacirca - 30 Nov 2022 Form 4 Insider Report for SPECTRUM PHARMACEUTICALS INC

Role
Director
Signature
/s/ Keith M. McGahan, Attorney-in-Fact for Jeffrey L. Vacirca
Issuer symbol
N/A
Transactions as of
30 Nov 2022
Net transactions value
+$22,500
Form type
4
Filing time
02 Dec 2022, 19:17:57 UTC
Previous filing
27 Oct 2022
Next filing
01 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPPI Common Stock, $0.001 par value Purchase $22,500 +50,000 +23% $0.4500 270,244 30 Nov 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices that when rounded to the nearest cent were equal to $0.45. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Excludes 25,000 restricted stock units granted on August 31, 2022.